Sp3 proteins negatively regulate beta myosin heavy chain gene expression during skeletal muscle inactivity

Area of Science:

• Molecular Biology
• Skeletal Muscle Physiology
• Gene Regulation

Background:

• Beta myosin heavy chain (betaMyHC) gene expression is specific to slow type I skeletal muscle fibers.
• Muscle inactivity leads to down-regulation of betaMyHC expression, but the underlying mechanisms are not fully understood.

Purpose of the Study:

• To investigate the role of Sp transcription factors in regulating betaMyHC gene expression in response to altered neuromuscular activity.
• To elucidate the signaling pathways mediating betaMyHC gene down-regulation during muscle inactivity.

Main Methods:

• Analysis of Sp3, Sp1, and Sp4 DNA binding to the betaMyHC promoter using nuclear extracts from skeletal muscle under different conditions (inactivity vs. mechanical overload).
• Reporter gene assays in Drosophila SL-2 and mouse C2C12 myotubes to assess the functional impact of Sp proteins on betaMyHC promoter activity.
• Investigation of competitive binding and transactivation effects of Sp proteins.

Main Results:

• Increased Sp3 binding to GC-rich elements in the betaMyHC promoter correlates with gene down-regulation during non-weight-bearing conditions.
• Decreased Sp3 binding and increased Sp1 binding are observed in response to mechanical overload, which up-regulates betaMyHC expression.
• An Sp4-DNA binding complex was detected in adult skeletal muscle nuclear extracts but not in cultured myotubes.
• Sp3 acts as a competitive inhibitor of Sp1-mediated betaMyHC transactivation.
• Sp4 shows weak activation in Sp1-deficient cells but not in Sp1-rich myotubes.

Conclusions:

• Competitive binding of Sp family proteins (Sp1, Sp3, Sp4) to the betaMyHC promoter plays a critical role in regulating its transcription in response to changes in neuromuscular activity.
• These findings identify Sp proteins as key mediators of functional adaptations in skeletal muscle gene expression.